In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Quantitative CMR perfusion mapping to detect microvascular dysfunction in patients without obstructive coronary disease

Session Rapid Fire Abstract 3: stress CMR: utility in coronary artery disease and beyond

Speaker Tushar Kotecha

Congress : EuroCMR 2019

  • Topic : imaging
  • Sub-topic : Stress CMR
  • Session type : Rapid Fire Abstracts
  • FP Number : 303

Authors : T Kotecha (London,GB), A Martinez-Naharro (London,GB), C Little (London,GB), LIZA Chacko (London,GB), G Manmathan (London,GB), JM Brown (London,GB), DS Knight (London,GB), PN Hawkins (London,GB), JM Moon (London,GB), H Xue (Bethesda,US), T Lockie (London,GB), RD Rakhit (London,GB), PN Kellman (Bethesda,US), N Patel (London,GB), M Fontana (London,GB)

15 views

Authors:
T Kotecha1 , A Martinez-Naharro1 , C Little1 , LIZA Chacko1 , G Manmathan1 , JM Brown1 , DS Knight1 , PN Hawkins1 , JM Moon2 , H Xue3 , T Lockie1 , RD Rakhit1 , PN Kellman3 , N Patel1 , M Fontana1 , 1Royal Free Hospital , Cardiology - London - United Kingdom of Great Britain & Northern Ireland , 2Barts Health NHS Trust - London - United Kingdom of Great Britain & Northern Ireland , 3National Institutes of Health - Bethesda - United States of America ,

Citation:
European Heart Journal - Cardiovascular Imaging ( 2019 ) 20 ( Supplement 2 ), ii223

Background 

Half of patients referred for invasive coronary angiography (ICA) for investigation of chest pain have angiographically non-obstructed coronary arteries (NOCAD). Index of microcirculatory resistance (IMR) is a useful tool for diagnosis of microvascular dysfunction (MVD) in patients with NOCAD but its use is limited due to its invasive nature. Adenosine stress CMR with myocardial perfusion mapping may have a role in the assessment of MVD as it allows for measurement of myocardial blood flow (MBF) at a pixelwise level.

Objective 

To assess the performance of myocardial perfusion mapping for the diagnosis of MVD in patients with NOCAD.

Methods 

Forty-four subjects (24 patients and 20 controls) underwent adenosine stress CMR with inline myocardial perfusion mapping at 1.5T using Gadgetron. The patients underwent ICA with measurement of fractional flow reserve (FFR) and IMR in all major epicardial vessels on the same day as the CMR. Perfusion maps were used to calculate global stress MBF and global myocardial perfusion reserve (MPR). 

Results 

All patients had NOCAD (defined as FFR >0.80 in all epicardial vessels) and no subjects had visual perfusion defects on first pass stress perfusion images. Fifteen patients had evidence of MVD defined as IMR >25 in at least one epicardial vessel and 9 patients had normal coronary physiology (NCP). Patients with MVD had significantly lower stress MBF compared to those with NCP and controls (MVD 2.11±0.31ml/g/min vs NCP 2.70±0.53ml/g/min vs controls 3.21±0.64ml/g/min, p<0.001). Both patients with MVD and NCP had lower MPR and higher rest MBF compared to controls (MPR: MVD 2.35±0.90 vs NCP 2.52±0.51 vs controls 4.25±0.81; rest MBF: MVD 1.03±0.35ml/g/min vs NCP 1.17±0.26ml/g/min vs controls 0.80±0.21ml/g/min; both p<0.001). Global stress MBF <2.23ml/g/min was able to detect MVD with sensitivity 80% and specificity 97% (AUC 0.93, p<0.001) and was superior to global MPR (AUC 0.82, p<0.05 for comparison)). 

Conclusions 

Patients with MVD have impaired stress MBF and this can be accurately detected using CMR perfusion mapping. Adenosine stress CMR with perfusion mapping is a useful diagnostic tool for the assessment of patients with angina and NOCAD.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are